This article was accepted into the corpus but its outbound wikilinks were never NER-processed — typical at the deepest BFS hop or when the run's entity cap was reached. No expansion funnel to show.
| ARRIVE guidelines | |
|---|---|
| Name | ARRIVE guidelines |
| Established | 2010 |
| Purpose | Reporting standards for animal research |
| Developers | National Centre for the Replacement, Refinement and Reduction of Animals in Research |
ARRIVE guidelines are a set of reporting recommendations intended to improve the design, conduct, and reporting of research using animals. They aim to enhance transparency, reproducibility, and ethical justification in preclinical studies by specifying essential information authors should include in manuscripts. The guidelines have been influential across journals, funding bodies, and institutions involved in biomedical research and laboratory animal science.
The ARRIVE initiative originated within frameworks emphasizing ethical oversight and methodological rigor linked to National Centre for the Replacement, Refinement and Reduction of Animals in Research activities and principles advocated by organisations such as Wellcome Trust, Medical Research Council, European Commission, and National Institutes of Health. It responds to critiques exemplified in high-profile discussions among stakeholders in Nature (journal), The Lancet, and Science (journal), and aligns with reporting movements related to CONSORT and PRISMA while addressing specifics of laboratory animal work overseen by bodies like Institutional Animal Care and Use Committee frameworks, Home Office (United Kingdom), and national regulatory agencies including Food and Drug Administration and European Medicines Agency.
The guidelines were published against a backdrop of systemic concerns highlighted by reviews from teams affiliated with University of Cambridge, University of Oxford, Johns Hopkins University, and University College London. Early development drew on expertise from researchers connected to Wellcome Trust Sanger Institute, Max Planck Society, and think tanks such as RAND Corporation. Workshops and consultations involved representatives from Royal Society, Academy of Medical Sciences, European Molecular Biology Organization, and advocacy groups like British Pharmacological Society. Major journal signatories included Nature (journal), PLOS ONE, The Journal of Physiology, and publishers such as Elsevier, Springer Nature, and Wiley-Blackwell.
The checklist sets out core items addressing experimental design elements that echo best practices promoted by institutions including National Academies of Sciences, Engineering, and Medicine, International Committee of Medical Journal Editors, and World Health Organization. Key checklist items cover ethical statements referencing oversight bodies like Institutional Animal Care and Use Committee and procedural details that relate to standards from American Veterinary Medical Association, European Convention for the Protection of Vertebrate Animals used for Experimental and other Scientific Purposes, and facility accreditation such as Association for Assessment and Accreditation of Laboratory Animal Care International. Reporting items include descriptions of species and strain often linked to sources like The Jackson Laboratory and European Mouse Mutant Archive, sample size calculations referencing methods promoted by Cochrane Collaboration and biostatistics groups at Harvard University, randomisation and blinding procedures mirroring recommendations from CONSORT, and outcome measures comparable with guidance from Food and Drug Administration and European Medicines Agency.
Adoption pathways involved coordination between funding agencies such as National Institutes of Health, Wellcome Trust, Medical Research Council, and publishers including PLOS, BMC, and Nature Publishing Group. Implementation strategies featured editorial policies instituted by outlets like The Lancet and operational guidelines at institutions such as University of Michigan, Stanford University, Massachusetts Institute of Technology, and Yale University. Training programmes invoked curricula from Society for Neuroscience, Federation of European Laboratory Animal Science Associations, and professional groups such as American Physiological Society and British Pharmacological Society. Monitoring and compliance mechanisms drew upon reporting audits performed by teams at University of Edinburgh and Karolinska Institute.
Analyses published by researchers at University of Glasgow, Imperial College London, Johns Hopkins University, and Columbia University assessed citation patterns and methodological transparency following guideline endorsement. Meta-research efforts by groups associated with Meta-Research Innovation Center at Stanford and Centre for Evidence-Based Medicine examined reproducibility crises discussed in venues like Proceedings of the National Academy of Sciences and Nature Reviews Neuroscience. The guidelines contributed to shifts in peer review practices at journals including PLOS Biology and BMJ, and influenced funding conditions set by European Research Council and National Health and Medical Research Council.
Critiques emerged from commentators affiliated with Lancet, Nature Medicine, and academics from University of Toronto and McGill University, questioning enforcement, completeness, and unintended administrative burden. Concerns paralleled debates involving Open Science Framework advocates and statisticians from University of California, Berkeley and London School of Economics. Other limitations noted by ethicists connected to Oxford University and policy analysts at Chatham House included variable uptake across disciplines, heterogeneity in journal endorsement exemplified by differences between PLOS and some specialty journals, and challenges in integrating with regulatory documentation from bodies like Home Office (United Kingdom) and Food and Drug Administration.
Revisions and extensions built on collaborations with consortia such as NC3Rs partners, researchers at University of Cambridge, University of Edinburgh, and metaresearch networks like UK Reproducibility Network. Related initiatives include reporting standards such as CONSORT, PRISMA, STROBE, and domain-specific extensions developed with stakeholders from Society for Neuroscience, European Society of Anaesthesiology, and International Association of Veterinary Editors. Cross-sector efforts linked to Open Science Framework, F1000Research, and funder policies at Wellcome Trust and European Commission continue to evolve reporting expectations.
Category:Research reporting guidelines